Patent ID: 11938179
Assignee: NOVAVAX, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 10:
11. The multivalent immunogenic polypeptide of claim 1, wherein:
(i) the CDT portion has an amino acid sequence that is at least 98% homologous to SEQ ID NO: 22;
(ii) the Toxin A portion has an amino acid sequence that is at least 98% homologous to SEQ ID NO: 24;
(iii) the first Toxin B portion has an amino acid sequence that is at least 98% homologous to SEQ ID NO: 23; and
(iv) the second Toxin B portion has an amino acid sequence that is at least 98% homologous to SEQ ID NO: 25.